British Columbia Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.68M | Sell |
|
|||||
|
2025
Q1 | $6.66M | Buy |
|
|||||
|
2024
Q4 | $5.78M | Buy |
|
|||||
|
2024
Q3 | $5.81M | Sell |
|
|||||
|
2024
Q2 | $5.88M | Buy |
|
|||||
|
2024
Q1 | $2.24M | Buy |
|
|||||
|
2023
Q4 | $2.75M | Buy |
|
|||||
|
2023
Q3 | $2M | Buy |
|
|||||
|
2023
Q2 | $2.12M | Buy |
|
|||||
|
2023
Q1 | $2.2M | Buy |
|
|||||
|
2022
Q4 | $2.53M | Sell |
|
|||||
|
2022
Q3 | $2.38M | Sell |
|
|||||
|
2022
Q2 | $2.03M | Sell |
|
|||||
|
2022
Q1 | $3.02M | Sell |
|
|||||
|
2021
Q4 | $3.55M | Sell |
|
|||||
|
2021
Q3 | $4.09M | Sell |
|
|||||
|
2021
Q2 | $3.67M | Buy |
|
|||||
|
2021
Q1 | $2.69M | Sell |
|
|||||
|
2020
Q4 | $2.54M | Sell |
|
|||||
|
2020
Q3 | $2.9M | Buy |
|
|||||
|
2020
Q2 | $2.67M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Sell |
|
|||||
|
2019
Q4 | $3.02M | Buy |
|
|||||
|
2019
Q3 | $1.38M | Sell |
|
|||||
|
2019
Q2 | $1.62M | Buy |
|
|||||
|
2019
Q1 | $1.94M | Sell |
|
|||||
|
2018
Q4 | $1.66M | Buy |
|
|||||
|
2018
Q3 | $1.74M | Sell |
|
|||||
|
2018
Q2 | $2.66M | Sell |
|
|||||
|
2018
Q1 | $3.96M | Sell |
|
|||||
|
2017
Q4 | $4.38M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $656K | Sell |
|
|||||
|
2016
Q2 | $798K | Hold |
|
|||||
|
2016
Q1 | $902K | Sell |
|
|||||
|
2015
Q4 | $4.52M | Buy |
|
|||||
|
2015
Q3 | $1.77M | Buy |
|
|||||
|
2015
Q2 | $1.94M | Buy |
|